Skip to main content

CCL19/MIP-3 beta Antibody (3A12)

Novus Biologicals, part of Bio-Techne | Catalog # NBP3-15143

Recombinant Monoclonal Antibody
Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP3-15143

Key Product Details

Species Reactivity

Validated:

Human

Applications

ELISA, Immunohistochemistry

Label

Unconjugated

Antibody Source

Recombinant Monoclonal Rabbit IgG Clone # 3A12

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Summary for CCL19/MIP-3 beta Antibody (3A12)

Immunogen

A synthesized peptide derived from human CCL19/MIP-3 beta. UniProt ID (Q99731).

Clonality

Monoclonal

Host

Rabbit

Isotype

IgG

Scientific Data Images for CCL19/MIP-3 beta Antibody (3A12)

Immunohistochemistry: CCL19/MIP-3 beta Antibody (3A12) [NBP3-15143]

Immunohistochemistry: CCL19/MIP-3 beta Antibody (3A12) [NBP3-15143]

Immunohistochemistry: CCL19/MIP-3 beta Antibody (3A12) [NBP3-15143] - IHC image of CCL19/MIP-3 beta antibody diluted at 1:155 and staining in paraffin-embedded human tonsil tissue. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30 minutes at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.
Immunohistochemistry: CCL19/MIP-3 beta Antibody (3A12) [NBP3-15143]

Immunohistochemistry: CCL19/MIP-3 beta Antibody (3A12) [NBP3-15143]

Immunohistochemistry: CCL19/MIP-3 beta Antibody (3A12) [NBP3-15143] - IHC image of CCL19/MIP-3 beta antibody diluted at 1:155 and staining in paraffin-embedded human appendix tissue. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30 minutes at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.

Applications for CCL19/MIP-3 beta Antibody (3A12)

Application
Recommended Usage

ELISA

Optimal dilutions of this antibody should be experimentally determined.

Immunohistochemistry

Optimal dilutions of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS (pH 7.4), 150mM NaCl, and 50% glycerol.

Preservative

0.02% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at -20 to -80C. Avoid freeze-thaw cycles.

Background: CCL19/MIP-3 beta

Macrophage Inflammatory Protein 3 beta is one of several CC cytokine genes clustered on the p-arm of chromosome 9. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene may play a role in normal lymphocyte recirculation and homing. It also plays an important role in trafficking of T cells in thymus, and in T cell and B cell migration to secondary lymphoid organs. It specifically binds to chemokine receptor CCR7. [provided by RefSeq]

Alternate Names

ELC, MIP-3 beta, MIP3 beta

Gene Symbol

CCL19

Additional CCL19/MIP-3 beta Products

Product Documents for CCL19/MIP-3 beta Antibody (3A12)

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for CCL19/MIP-3 beta Antibody (3A12)

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...